Antithrombin III for critically ill patients

Citation: Allingstrup  M, Wetterslev  J, Ravn  FB, et al. Antithrombin III for critically ill patients. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD005370. DOI: 10.1002/14651858.CD005370.pub3.

Antithrombin III (AT III) cannot be recommended for critically ill patients based on the available evidence.

Critical illness is associated with uncontrolled inflammation and vascular damage which can result in multiple organ failure and death. AT III is an anticoagulant with anti-inflammatory properties but the efficacy and any harmful effects of AT III supplementation in critically ill patients are unknown. This review assesses the benefits and harms of AT III in critically ill patients.

الإنكار 免责声明 免責聲明 Disclaimer Clause de non-responsabilité Haftungsausschluss Disclaimer 免責事項 Aviso legal Exención de responsabilidad